AG
ARRY
Artal Group’s Array Biopharma Inc ARRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,000,000
| Closed | -$48.8M | – | 118 |
|
|
2019
Q1 | $48.8M | Sell |
2,000,000
-500,000
| -20% | -$12.2M | 1.99% | 10 |
|
|
2018
Q4 | $35.6M | Buy |
2,500,000
+600,000
| +32% | +$8.55M | 1.32% | 11 |
|
|
2018
Q3 | $28.9M | Sell |
1,900,000
-100,000
| -5% | -$1.52M | 0.75% | 15 |
|
|
2018
Q2 | $33.6M | Hold |
2,000,000
| – | – | 0.71% | 12 |
|
|
2018
Q1 | $32.6M | Buy |
2,000,000
+500,000
| +33% | +$8.16M | 0.41% | 13 |
|
|
2017
Q4 | $19.2M | Hold |
1,500,000
| – | – | 0.29% | 12 |
|
|
2017
Q3 | $18.5M | Buy |
1,500,000
+550,000
| +58% | +$6.77M | 0.32% | 13 |
|
|
2017
Q2 | $7.95M | Buy |
950,000
+200,000
| +27% | +$1.67M | 0.14% | 23 |
|
|
2017
Q1 | $6.71M | Sell |
750,000
-500,000
| -40% | -$4.47M | 0.15% | 32 |
|
|
2016
Q4 | $11M | Sell |
1,250,000
-2,250,000
| -64% | -$19.8M | 0.24% | 16 |
|
|
2016
Q3 | $23.6M | Sell |
3,500,000
-370,000
| -10% | -$2.5M | 0.47% | 10 |
|
|
2016
Q2 | $13.8M | Buy |
3,870,000
+160,000
| +4% | +$570K | 0.28% | 17 |
|
|
2016
Q1 | $10.9M | Hold |
3,710,000
| – | – | 0.21% | 20 |
|
|
2015
Q4 | $15.7M | Hold |
3,710,000
| – | – | 0.29% | 17 |
|
|
2015
Q3 | $16.9M | Hold |
3,710,000
| – | – | 0.38% | 13 |
|
|
2015
Q2 | $26.7M | Hold |
3,710,000
| – | – | 1.15% | 11 |
|
|
2015
Q1 | $27.3M | Buy |
3,710,000
+710,000
| +24% | +$5.23M | 1.26% | 11 |
|
|
2014
Q4 | $14.2M | Hold |
3,000,000
| – | – | 0.5% | 16 |
|
|
2014
Q3 | $10.7M | Hold |
3,000,000
| – | – | 0.39% | 17 |
|
|
2014
Q2 | $13.7M | Hold |
3,000,000
| – | – | 0.55% | 14 |
|
|
2014
Q1 | $14.1M | Hold |
3,000,000
| – | – | 0.51% | 11 |
|
|
2013
Q4 | $15M | Hold |
3,000,000
| – | – | 0.54% | 11 |
|
|
2013
Q3 | $18.7M | Hold |
3,000,000
| – | – | 0.61% | 8 |
|
|
2013
Q2 | $13.6M | Buy |
+3,000,000
| New | +$13.6M | 0.43% | 14 |
|